Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05925491
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-09
First Post:
2023-06-21
Brief Title:
Pembrolizumab in Locally Advanced Sinonasal Carcinoma
Sponsor:
Istituti Clinici Scientifici Maugeri SpA
Organization:
Istituti Clinici Scientifici Maugeri SpA
Organization Data
Organization:
Istituti Clinici Scientifici Maugeri SpA
Class:
OTHER
Study ID:
NeoPeSino
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Istituti Clinici Scientifici Maugeri SpA
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |